GSK — GSK plc
Median target
$55.05
calls from the last 12 months
Implied return
+7.8%
median target vs. price
Coverage
7 analysts · 8 calls
updated in the last 12 months
Consensus
3/1/30 net
Buy / Hold / Sell
Which analysts are behind GSK's consensus?
See every current rating, price target and the analysts' track records for GSK plc — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 7 analysts with calls on GSK updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
GSK elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2025-10-30 | Congress | Lisa McClainMI-MI09 | Sale | since trade +10.8%, vs market +1.9% | $1K–$15K |
| 2025-09-23 | Congress | Valerie HoyleOR-OR04 | Sale | since trade +28.3%, vs market -12.8% | $1K–$15K |
| 2024-11-25 | Congress | Marjorie Taylor Mrs GreeneGA-GA14 | Purchase | since trade +57.4%, vs market +27.7% | $1K–$15K |
| 2023-07-10 | Congress | Daniel GoldmanNY-NY10 | Sale | since trade +68.5%, vs market +10.9% | $15K–$50K |
| 2023-03-01 | Congress | Virginia FoxxNC-NC05 | Sale | since trade +68.1%, vs market +33.2% | $50K–$100K |
| 2022-08-09 | Congress | Virginia FoxxNC-NC05 | Purchase | since trade +48.3%, vs market -46.5% | $1K–$15K |
| 2022-08-05 | Congress | Virginia FoxxNC-NC05 | Purchase | since trade +46.3%, vs market -47.5% | $15K–$50K |
| 2022-07-12 | Congress | Virginia FoxxNC-NC05 | Sale | since trade +43.3%, vs market +67.2% | $100K–$250K |
| 2022-07-06 | Congress | Virginia FoxxNC-NC05 | Purchase | since trade +37.7%, vs market -71.4% | $1K–$15K |
| 2022-04-08 | Congress | Virginia FoxxNC-NC05 | Purchase | since trade +28.3%, vs market -51.5% | $1K–$15K |
More: congressional trades on GSK · insider activity · executive branch · trending